E. Ohman J:Or Asset Management Ab Biomarin Pharmaceutical Inc Transaction History

E. Ohman J:Or Asset Management Ab

$4.04 Trillion
Q3 2024

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 05, 2024	SELL	$74.28 - $92.69 $616,524 - $769,327	-8,300 Closed	0 $0
Q3 2021 Apr 05, 2024	SELL	$74.77 - $85.47 $97,201 - $111,111	-1,300 Reduced 13.54%	8,300 $642 Million
Q4 2020 Apr 05, 2024	BUY	$72.61 - $90.2 $181,525 - $225,500	2,500 Added 35.21%	9,600 $842 Million
Q3 2020 Apr 05, 2024	SELL	$71.87 - $131.03 $18.6 Million - $33.8 Million	-258,137 Reduced 97.32%	7,100 $540 Million
Q2 2020 Apr 05, 2024	BUY	$79.55 - $124.22 $2.17 Million - $3.39 Million	27,317 Added 11.48%	265,237 $32.7 Billion
Q1 2020 Apr 05, 2024	BUY	$71.37 - $96.85 $1.96 Million - $2.66 Million	27,497 Added 13.07%	237,920 $20.1 Billion
Q4 2019 Apr 05, 2024	BUY	$64.27 - $86.37 $2.56 Million - $3.44 Million	39,830 Added 23.35%	210,423 $17.8 Billion
Q3 2019 Apr 05, 2024	BUY	$67.4 - $85.11 $11.2 Million - $14.2 Million	166,393 Added 3961.74%	170,593 $11.5 Billion
Q2 2019 Apr 05, 2024	SELL	$80.35 - $93.9 $329,435 - $384,990	-4,100 Reduced 49.4%	4,200 $360 Million
Q3 2018 Apr 05, 2024	BUY	$93.92 - $105.72 $75,136 - $84,576	800 Added 10.67%	8,300 $805 Million
Q2 2018 Apr 05, 2024	BUY	$76.01 - $99.03 $205,227 - $267,381	2,700 Added 56.25%	7,500 $707 Million
Q1 2018 Apr 05, 2024	SELL	$77.67 - $92.63 $93,204 - $111,156	-1,200 Reduced 20.0%	4,800 $389 Million
Q4 2017 Apr 05, 2024	BUY	$80.76 - $95.13 $72,684 - $85,617	900 Added 17.65%	6,000 $535 Million
Q3 2017 Apr 05, 2024	BUY	$80.6 - $94.95 $8,059 - $9,495	100 Added 2.0%	5,100 $475 Million
Q1 2017 Apr 05, 2024	BUY	N/A	1,700 Added 51.52%	5,000 $439 Million
Q2 2013 Apr 05, 2024	BUY	N/A	3,300	3,300 $184 Million

Others Institutions Holding BMRN

# of Institutions

637

Shares Held

177M

Call Options Held

2.01M

Put Options Held

1.28M

Black Rock Inc. New York, NY

22.7M
Shares

$1.52 Billion
0.04% of portfolio
Vanguard Group Inc Valley Forge, PA

19.3M
Shares

$1.28 Billion
0.02% of portfolio
Primecap Management CO Pasadena, CA

18.9M
Shares

$1.26 Billion
0.99% of portfolio
Dodge & Cox San Francisco, CA

13.9M
Shares

$926 Million
0.59% of portfolio
Capital Research Global Investors Los Angeles, CA

10.5M
Shares

$699 Million
0.16% of portfolio

View Full List

About BIOMARIN PHARMACEUTICAL INC

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $12.4B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

More about BMRN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of E. Ohman J:Or Asset Management Ab, based on Form 13F filings with the SEC.

News

Stay updated on E. Ohman J:Or Asset Management Ab with notifications on news.

Account